NO860180L - - Google Patents
Info
- Publication number
- NO860180L NO860180L NO860180A NO860180A NO860180L NO 860180 L NO860180 L NO 860180L NO 860180 A NO860180 A NO 860180A NO 860180 A NO860180 A NO 860180A NO 860180 L NO860180 L NO 860180L
- Authority
- NO
- Norway
- Prior art keywords
- cellulose
- cells
- fibers
- meq
- cell
- Prior art date
Links
- 210000004027 cell Anatomy 0.000 claims description 110
- 229920002678 cellulose Polymers 0.000 claims description 57
- 239000001913 cellulose Substances 0.000 claims description 57
- 239000000835 fiber Substances 0.000 claims description 56
- 210000002950 fibroblast Anatomy 0.000 claims description 18
- 229920003043 Cellulose fiber Polymers 0.000 claims description 15
- 238000000034 method Methods 0.000 claims description 15
- MZVQCMJNVPIDEA-UHFFFAOYSA-N [CH2]CN(CC)CC Chemical compound [CH2]CN(CC)CC MZVQCMJNVPIDEA-UHFFFAOYSA-N 0.000 claims description 13
- 238000005349 anion exchange Methods 0.000 claims description 13
- 230000012010 growth Effects 0.000 claims description 13
- 241000700605 Viruses Species 0.000 claims description 10
- 238000005342 ion exchange Methods 0.000 claims description 9
- 238000004519 manufacturing process Methods 0.000 claims description 8
- 229960005486 vaccine Drugs 0.000 claims description 8
- 210000001840 diploid cell Anatomy 0.000 claims description 7
- 239000001963 growth medium Substances 0.000 claims description 7
- 239000000725 suspension Substances 0.000 claims description 7
- 239000006185 dispersion Substances 0.000 claims description 6
- -1 diethyl-(2-hydroxypropyl)aminoethyl Chemical group 0.000 claims description 5
- 125000000022 2-aminoethyl group Chemical group [H]C([*])([H])C([H])([H])N([H])[H] 0.000 claims description 4
- 210000005260 human cell Anatomy 0.000 claims description 4
- 239000002356 single layer Substances 0.000 claims description 4
- 241000124008 Mammalia Species 0.000 claims description 3
- 125000003277 amino group Chemical group 0.000 claims description 3
- 229920001425 Diethylaminoethyl cellulose Polymers 0.000 claims description 2
- 210000000712 G cell Anatomy 0.000 claims 1
- 239000002609 medium Substances 0.000 description 15
- 238000002474 experimental method Methods 0.000 description 14
- 239000000463 material Substances 0.000 description 13
- SEQKRHFRPICQDD-UHFFFAOYSA-N N-tris(hydroxymethyl)methylglycine Chemical compound OCC(CO)(CO)[NH2+]CC([O-])=O SEQKRHFRPICQDD-UHFFFAOYSA-N 0.000 description 10
- 238000004113 cell culture Methods 0.000 description 10
- 238000011534 incubation Methods 0.000 description 9
- 238000004114 suspension culture Methods 0.000 description 9
- 241000709701 Human poliovirus 1 Species 0.000 description 7
- 238000002360 preparation method Methods 0.000 description 7
- UIIMBOGNXHQVGW-UHFFFAOYSA-M Sodium bicarbonate Chemical compound [Na+].OC([O-])=O UIIMBOGNXHQVGW-UHFFFAOYSA-M 0.000 description 6
- 108090000623 proteins and genes Proteins 0.000 description 6
- 102000004169 proteins and genes Human genes 0.000 description 6
- 238000004809 thin layer chromatography Methods 0.000 description 6
- 239000007997 Tricine buffer Substances 0.000 description 5
- 150000001450 anions Chemical class 0.000 description 5
- 210000004072 lung Anatomy 0.000 description 5
- 210000002966 serum Anatomy 0.000 description 5
- GUBGYTABKSRVRQ-WFVLMXAXSA-N DEAE-cellulose Chemical compound OC1C(O)C(O)C(CO)O[C@H]1O[C@@H]1C(CO)OC(O)C(O)C1O GUBGYTABKSRVRQ-WFVLMXAXSA-N 0.000 description 4
- 239000006145 Eagle's minimal essential medium Substances 0.000 description 4
- 241000991587 Enterovirus C Species 0.000 description 4
- 206010028980 Neoplasm Diseases 0.000 description 4
- 229920002873 Polyethylenimine Polymers 0.000 description 4
- UZMAPBJVXOGOFT-UHFFFAOYSA-N Syringetin Natural products COC1=C(O)C(OC)=CC(C2=C(C(=O)C3=C(O)C=C(O)C=C3O2)O)=C1 UZMAPBJVXOGOFT-UHFFFAOYSA-N 0.000 description 4
- 244000309466 calf Species 0.000 description 4
- 201000011510 cancer Diseases 0.000 description 4
- KCFYHBSOLOXZIF-UHFFFAOYSA-N dihydrochrysin Natural products COC1=C(O)C(OC)=CC(C2OC3=CC(O)=CC(O)=C3C(=O)C2)=C1 KCFYHBSOLOXZIF-UHFFFAOYSA-N 0.000 description 4
- LOKCTEFSRHRXRJ-UHFFFAOYSA-I dipotassium trisodium dihydrogen phosphate hydrogen phosphate dichloride Chemical compound P(=O)(O)(O)[O-].[K+].P(=O)(O)([O-])[O-].[Na+].[Na+].[Cl-].[K+].[Cl-].[Na+] LOKCTEFSRHRXRJ-UHFFFAOYSA-I 0.000 description 4
- ZDXPYRJPNDTMRX-UHFFFAOYSA-N glutamine Natural products OC(=O)C(N)CCC(N)=O ZDXPYRJPNDTMRX-UHFFFAOYSA-N 0.000 description 4
- 239000002953 phosphate buffered saline Substances 0.000 description 4
- DAEPDZWVDSPTHF-UHFFFAOYSA-M sodium pyruvate Chemical compound [Na+].CC(=O)C([O-])=O DAEPDZWVDSPTHF-UHFFFAOYSA-M 0.000 description 4
- 239000000758 substrate Substances 0.000 description 4
- 102000004142 Trypsin Human genes 0.000 description 3
- 108090000631 Trypsin Proteins 0.000 description 3
- 230000010261 cell growth Effects 0.000 description 3
- 230000001419 dependent effect Effects 0.000 description 3
- 230000000694 effects Effects 0.000 description 3
- 239000012737 fresh medium Substances 0.000 description 3
- 238000000338 in vitro Methods 0.000 description 3
- 208000015181 infectious disease Diseases 0.000 description 3
- 210000001161 mammalian embryo Anatomy 0.000 description 3
- 229910000030 sodium bicarbonate Inorganic materials 0.000 description 3
- 235000017557 sodium bicarbonate Nutrition 0.000 description 3
- 229910001220 stainless steel Inorganic materials 0.000 description 3
- 239000010935 stainless steel Substances 0.000 description 3
- 239000012588 trypsin Substances 0.000 description 3
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 2
- 241000282693 Cercopithecidae Species 0.000 description 2
- 241000287828 Gallus gallus Species 0.000 description 2
- 150000001768 cations Chemical class 0.000 description 2
- 210000004748 cultured cell Anatomy 0.000 description 2
- 238000010790 dilution Methods 0.000 description 2
- 239000012895 dilution Substances 0.000 description 2
- 210000002257 embryonic structure Anatomy 0.000 description 2
- 239000007788 liquid Substances 0.000 description 2
- 238000010899 nucleation Methods 0.000 description 2
- 229920000642 polymer Polymers 0.000 description 2
- 229940076788 pyruvate Drugs 0.000 description 2
- 229940054269 sodium pyruvate Drugs 0.000 description 2
- 238000003756 stirring Methods 0.000 description 2
- XSNSOQNHJHPRQG-UHFFFAOYSA-N 2-[bis(2-hydroxyethyl)amino]ethanol;2-(chloromethyl)oxirane Chemical compound ClCC1CO1.OCCN(CCO)CCO XSNSOQNHJHPRQG-UHFFFAOYSA-N 0.000 description 1
- 208000030507 AIDS Diseases 0.000 description 1
- 241000271566 Aves Species 0.000 description 1
- BVKZGUZCCUSVTD-UHFFFAOYSA-M Bicarbonate Chemical compound OC([O-])=O BVKZGUZCCUSVTD-UHFFFAOYSA-M 0.000 description 1
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 1
- 241000282472 Canis lupus familiaris Species 0.000 description 1
- 102000004190 Enzymes Human genes 0.000 description 1
- 108090000790 Enzymes Proteins 0.000 description 1
- 241000283086 Equidae Species 0.000 description 1
- 241000282326 Felis catus Species 0.000 description 1
- 208000007212 Foot-and-Mouth Disease Diseases 0.000 description 1
- 241000710198 Foot-and-mouth disease virus Species 0.000 description 1
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 1
- 241000941423 Grom virus Species 0.000 description 1
- 241000709704 Human poliovirus 2 Species 0.000 description 1
- XQFRJNBWHJMXHO-RRKCRQDMSA-N IDUR Chemical compound C1[C@H](O)[C@@H](CO)O[C@H]1N1C(=O)NC(=O)C(I)=C1 XQFRJNBWHJMXHO-RRKCRQDMSA-N 0.000 description 1
- 102000014150 Interferons Human genes 0.000 description 1
- 108010050904 Interferons Proteins 0.000 description 1
- FYYHWMGAXLPEAU-UHFFFAOYSA-N Magnesium Chemical compound [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 description 1
- 201000005505 Measles Diseases 0.000 description 1
- 241000699670 Mus sp. Species 0.000 description 1
- 241001494479 Pecora Species 0.000 description 1
- 101100388690 Plasmodium falciparum (isolate K1 / Thailand) MEF-1 gene Proteins 0.000 description 1
- 208000000474 Poliomyelitis Diseases 0.000 description 1
- 229940124867 Poliovirus vaccine Drugs 0.000 description 1
- 206010037742 Rabies Diseases 0.000 description 1
- 241000700159 Rattus Species 0.000 description 1
- 241000283984 Rodentia Species 0.000 description 1
- 241000282887 Suidae Species 0.000 description 1
- 241000251539 Vertebrata <Metazoa> Species 0.000 description 1
- 238000009825 accumulation Methods 0.000 description 1
- 238000004220 aggregation Methods 0.000 description 1
- 230000002776 aggregation Effects 0.000 description 1
- 238000004873 anchoring Methods 0.000 description 1
- 210000004102 animal cell Anatomy 0.000 description 1
- 230000000890 antigenic effect Effects 0.000 description 1
- 239000011324 bead Substances 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 239000011575 calcium Substances 0.000 description 1
- 229910052791 calcium Inorganic materials 0.000 description 1
- 239000000969 carrier Substances 0.000 description 1
- 239000006285 cell suspension Substances 0.000 description 1
- 125000003636 chemical group Chemical group 0.000 description 1
- 230000000052 comparative effect Effects 0.000 description 1
- 238000007796 conventional method Methods 0.000 description 1
- 238000012258 culturing Methods 0.000 description 1
- 230000003247 decreasing effect Effects 0.000 description 1
- 239000012153 distilled water Substances 0.000 description 1
- 238000009826 distribution Methods 0.000 description 1
- 210000002919 epithelial cell Anatomy 0.000 description 1
- 230000001605 fetal effect Effects 0.000 description 1
- 239000012847 fine chemical Substances 0.000 description 1
- 210000003953 foreskin Anatomy 0.000 description 1
- 239000008103 glucose Substances 0.000 description 1
- 229940088597 hormone Drugs 0.000 description 1
- 239000005556 hormone Substances 0.000 description 1
- 206010022000 influenza Diseases 0.000 description 1
- 238000011081 inoculation Methods 0.000 description 1
- 239000002054 inoculum Substances 0.000 description 1
- 229940079322 interferon Drugs 0.000 description 1
- 150000002500 ions Chemical class 0.000 description 1
- 210000003292 kidney cell Anatomy 0.000 description 1
- 238000011031 large-scale manufacturing process Methods 0.000 description 1
- 239000010410 layer Substances 0.000 description 1
- 239000011777 magnesium Substances 0.000 description 1
- 229910052749 magnesium Inorganic materials 0.000 description 1
- 210000004962 mammalian cell Anatomy 0.000 description 1
- 238000009343 monoculture Methods 0.000 description 1
- 230000000877 morphologic effect Effects 0.000 description 1
- 230000001338 necrotic effect Effects 0.000 description 1
- 229910052757 nitrogen Inorganic materials 0.000 description 1
- 231100000590 oncogenic Toxicity 0.000 description 1
- 230000002246 oncogenic effect Effects 0.000 description 1
- 210000000056 organ Anatomy 0.000 description 1
- 229960001539 poliomyelitis vaccine Drugs 0.000 description 1
- 239000000843 powder Substances 0.000 description 1
- 239000000047 product Substances 0.000 description 1
- 208000009305 pseudorabies Diseases 0.000 description 1
- 230000001105 regulatory effect Effects 0.000 description 1
- 201000005404 rubella Diseases 0.000 description 1
- 238000013376 serial cultivation Methods 0.000 description 1
- 210000003491 skin Anatomy 0.000 description 1
- 239000006228 supernatant Substances 0.000 description 1
- 230000035899 viability Effects 0.000 description 1
- 230000003612 virological effect Effects 0.000 description 1
- 239000005723 virus inoculator Substances 0.000 description 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/0068—General culture methods using substrates
- C12N5/0075—General culture methods using substrates using microcarriers
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2533/00—Supports or coatings for cell culture, characterised by material
- C12N2533/70—Polysaccharides
- C12N2533/78—Cellulose
-
- F—MECHANICAL ENGINEERING; LIGHTING; HEATING; WEAPONS; BLASTING
- F02—COMBUSTION ENGINES; HOT-GAS OR COMBUSTION-PRODUCT ENGINE PLANTS
- F02B—INTERNAL-COMBUSTION PISTON ENGINES; COMBUSTION ENGINES IN GENERAL
- F02B61/00—Adaptations of engines for driving vehicles or for driving propellers; Combinations of engines with gearing
- F02B61/04—Adaptations of engines for driving vehicles or for driving propellers; Combinations of engines with gearing for driving propellers
- F02B61/045—Adaptations of engines for driving vehicles or for driving propellers; Combinations of engines with gearing for driving propellers for marine engines
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Biomedical Technology (AREA)
- Biotechnology (AREA)
- Organic Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Genetics & Genomics (AREA)
- Wood Science & Technology (AREA)
- Zoology (AREA)
- Microbiology (AREA)
- Biochemistry (AREA)
- General Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Cell Biology (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| SE8402742A SE454518B (sv) | 1984-05-21 | 1984-05-21 | Forfarande for odling av diploida celler i nervaro av cellulosafibrer |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| NO860180L true NO860180L (pt) | 1986-01-20 |
Family
ID=20355970
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO860180A NO860180L (pt) | 1984-05-21 | 1986-01-20 |
Country Status (6)
| Country | Link |
|---|---|
| EP (1) | EP0216771A1 (pt) |
| JP (1) | JPS62500001A (pt) |
| DK (1) | DK19086A (pt) |
| NO (1) | NO860180L (pt) |
| SE (1) | SE454518B (pt) |
| WO (1) | WO1985005375A1 (pt) |
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE3402927A1 (de) * | 1984-01-28 | 1985-08-08 | Pfeifer & Langen, 5000 Köln | Zellkulturmikrotraeger, verfahren zu seiner herstellung und seine verwendung zum zuechten von verankerungsabhaengigen zellen |
| US4874810A (en) * | 1986-03-07 | 1989-10-17 | General Electric Company | Impact modified polyphenylene ether-polyamide compositions |
| US9278730B2 (en) | 2009-12-30 | 2016-03-08 | Alex R. Kaye and Frances Kaye Trust | Brace for folding transom |
| US8539900B2 (en) | 2009-12-30 | 2013-09-24 | Alex R. Kaye and Frances Kaye Trust | Folding transom for a collapsible boat |
| JP5846550B2 (ja) * | 2011-05-02 | 2016-01-20 | 国立研究開発法人物質・材料研究機構 | 短繊維足場材料、短繊維−細胞複合凝集塊作製方法及び短繊維−細胞複合凝集塊 |
| TW201738256A (zh) * | 2016-04-04 | 2017-11-01 | 日產化學工業股份有限公司 | 蛋白質產生方法 |
| JP6799316B2 (ja) * | 2016-09-12 | 2020-12-16 | 国立研究開発法人物質・材料研究機構 | 配向性を有する短繊維−細胞複合凝集塊を製造するための方法 |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ZA776251B (en) * | 1976-11-11 | 1978-07-26 | Massachusetts Inst Technology | Improved cell culture microcarriers |
| FR2396083A1 (fr) * | 1977-06-30 | 1979-01-26 | Merieux Inst | Procede de culture de virus |
| US4352887A (en) * | 1979-10-29 | 1982-10-05 | Albert Einstein College Of Medicine Of Yeshiva University | Method and article for culturing differentiated cells |
| JPS59164723A (ja) * | 1983-03-10 | 1984-09-17 | Koken:Kk | 再生コラーゲンフイブリルを含有する基質及びその製造方法 |
-
1984
- 1984-05-21 SE SE8402742A patent/SE454518B/sv not_active IP Right Cessation
-
1985
- 1985-05-21 WO PCT/SE1985/000213 patent/WO1985005375A1/en not_active Application Discontinuation
- 1985-05-21 EP EP85902710A patent/EP0216771A1/en not_active Withdrawn
- 1985-05-21 JP JP60502558A patent/JPS62500001A/ja active Pending
-
1986
- 1986-01-15 DK DK19086A patent/DK19086A/da not_active Application Discontinuation
- 1986-01-20 NO NO860180A patent/NO860180L/no unknown
Also Published As
| Publication number | Publication date |
|---|---|
| WO1985005375A1 (en) | 1985-12-05 |
| DK19086A (da) | 1986-03-03 |
| SE8402742L (sv) | 1985-11-22 |
| SE8402742D0 (sv) | 1984-05-21 |
| DK19086D0 (da) | 1986-01-15 |
| EP0216771A1 (en) | 1987-04-08 |
| SE454518B (sv) | 1988-05-09 |
| JPS62500001A (ja) | 1987-01-08 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP5264812B2 (ja) | Ｍｄｃｋ細胞懸濁培養物において薬物または診断剤の活性成分を生成する方法 | |
| AU2002338666B2 (en) | Multiplication of viruses in a cell culture | |
| JP2006320328A (ja) | ウィルス増殖のための不死化細胞系 | |
| Wong et al. | Changing viral susceptibility of a human cell line in continuous cultivation: I. Production of infective virus in a variant of the Chang conjunctival cell following infection with swine or N-WS influenza viruses | |
| CZ258996A3 (en) | Process for preparing a great amount of virus | |
| KR101835100B1 (ko) | 부착성 세포를 배양하는 방법 | |
| HU225791B1 (en) | Method for large scale production of virus antigen | |
| Berry et al. | Production of reovirus type‐1 and type‐3 from Vero cells grown on solid and macroporous microcarriers | |
| CN104152403B (zh) | 一种建立鹅胚上皮细胞系的方法及建立的鹅胚上皮细胞系 | |
| NO860180L (pt) | ||
| US3935066A (en) | Cell lines | |
| US9932562B2 (en) | Drain down and re-feed of microcarrier bioreactor | |
| FI98377C (fi) | Adherentisti sitoutuneita soluja sisältävä matriisi ja menetelmä virus/virusantigeenin tuottamiseksi | |
| US4169761A (en) | Process for the cultivation of viruses | |
| Moran | A microcarrier-based cell culture process for the production of a bovine respiratory syncytial virus vaccine | |
| CN109666653B (zh) | 一种狂犬病疫苗病毒的传代培养方法、狂犬病疫苗的制备方法 | |
| CN106085947B (zh) | Mdck克隆细胞株及其应用 | |
| JPS63501474A (ja) | 細胞を培養するための微小担体を製造するための方法及び該方法によって製造された微小担体 | |
| Hayle | Culture of respiratory syncytial virus infected diploid bovine nasal mucosa cells on cytodex 3 microcarriers | |
| CN115627252A (zh) | 人肺胚细胞系及其应用 | |
| Kusano et al. | General characteristics of the cells transformed in vitro by human adenovirus type 12 | |
| CN114934020A (zh) | 猪视网膜上皮细胞系及其建立方法和应用 | |
| Tatiana et al. | Primary cell culture. Cell culture | |
| CN111826339A (zh) | 一株Vero单克隆细胞系及其应用 | |
| RU2140451C1 (ru) | Штамм культивируемых клеток почки suis domestica l. для культивирования вирусов животных |